Tags

Type your tag names separated by a space and hit enter

Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic.
ASAIO J. 2020 Nov/Dec; 66(10):1069-1072.AJ

Abstract

Extracorporeal membrane oxygenation (ECMO) is recognized as organ support for potentially reversible acute respiratory distress syndrome (ARDS). However, limited resource during the outbreak and the coagulopathy associated with coronavirus disease 2019 (COVID-19) make the utilization of venovenous (VV) ECMO highly challenging. We herein report specific considerations for cannulation configurations and ECMO management during the pandemic. High blood flow and anticoagulation at higher levels than usual practice for VV ECMO may be required because of thrombotic hematologic profile of COVID-19. Among our first 24 cases (48.8 ± 8.9 years), 17 patients were weaned from ECMO after a mean duration of 19.0 ± 10.1 days and 16 of them have been discharged from ICU.

Authors+Show Affiliations

From the Department of Cardiac Surgery, Pulmonary Hypertension National Referral Center, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, Paris, France. Paris-Saclay University School of Medicine, Le Kremlin-Bicêtre, France. INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France.Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.Department of Anesthesiology, Pain, and Perioperative Medicine, Division of Critical Care Medicine, Stanford University School of Medicine, California.Department of Anesthesiology and Intensive Care, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, Paris, France.From the Department of Cardiac Surgery, Pulmonary Hypertension National Referral Center, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Le Plessis Robinson, Paris, France.Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, Paris, France.Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitié-Salpêtrière Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Sorbonne University Medical School, Paris, France. INSERM, UMRS 1166-ICAN, Institute of Cardiometabolism and Nutrition, Paris, France.Paris-Saclay University School of Medicine, Le Kremlin-Bicêtre, France. INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France. Department of Anesthesiology and Intensive Care, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, Paris, France.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33136589

Citation

Guihaire, Julien, et al. "Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic." ASAIO Journal (American Society for Artificial Internal Organs : 1992), vol. 66, no. 10, 2020, pp. 1069-1072.
Guihaire J, Owyang CG, Madhok J, et al. Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic. ASAIO J. 2020;66(10):1069-1072.
Guihaire, J., Owyang, C. G., Madhok, J., Laverdure, F., Gaillard, M., Girault, A., Lebreton, G., & Mercier, O. (2020). Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic. ASAIO Journal (American Society for Artificial Internal Organs : 1992), 66(10), 1069-1072. https://doi.org/10.1097/MAT.0000000000001251
Guihaire J, et al. Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic. ASAIO J. 2020 Nov/Dec;66(10):1069-1072. PubMed PMID: 33136589.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic. AU - Guihaire,Julien, AU - Owyang,Clark G, AU - Madhok,Jai, AU - Laverdure,Florent, AU - Gaillard,Maïra, AU - Girault,Antoine, AU - Lebreton,Guillaume, AU - Mercier,Olaf, PY - 2020/11/2/entrez PY - 2020/11/3/pubmed PY - 2020/11/20/medline SP - 1069 EP - 1072 JF - ASAIO journal (American Society for Artificial Internal Organs : 1992) JO - ASAIO J VL - 66 IS - 10 N2 - Extracorporeal membrane oxygenation (ECMO) is recognized as organ support for potentially reversible acute respiratory distress syndrome (ARDS). However, limited resource during the outbreak and the coagulopathy associated with coronavirus disease 2019 (COVID-19) make the utilization of venovenous (VV) ECMO highly challenging. We herein report specific considerations for cannulation configurations and ECMO management during the pandemic. High blood flow and anticoagulation at higher levels than usual practice for VV ECMO may be required because of thrombotic hematologic profile of COVID-19. Among our first 24 cases (48.8 ± 8.9 years), 17 patients were weaned from ECMO after a mean duration of 19.0 ± 10.1 days and 16 of them have been discharged from ICU. SN - 1538-943X UR - https://www.unboundmedicine.com/medline/citation/33136589/Specific_Considerations_for_Venovenous_Extracorporeal_Membrane_Oxygenation_During_Coronavirus_Disease_2019_Pandemic_ L2 - https://doi.org/10.1097/MAT.0000000000001251 DB - PRIME DP - Unbound Medicine ER -